Publications by authors named "Anju Anand"
Article Synopsis
- The study aimed to analyze sleep breathing disorders in adults with cystic fibrosis (CF), focusing on how common they are, risk factors, and treatment options.
- Out of 42 patients, obstructive sleep apnea (OSA) was the most common disorder (64.3%), with many not receiving adequate treatment like positive airway pressure (PAP) therapy.
- The research found a strong link between corticosteroid use and sleep breathing disorders, highlighting a care gap in managing these issues that requires further investigation.
Combination Nintedanib and Pirfenidone for Treatment of Idiopathic Pulmonary Fibrosis.
Am J Respir Crit Care Med
October 2018
eHealth in Cystic Fibrosis: Promising, but Proof of Concept Is Still Needed.
Am J Respir Crit Care Med
July 2018
Written Action Asthma Plans: Not Such a Simple Issue in Subspecialist Care?
Am J Respir Crit Care Med
January 2016
Background: The high prevalence of internet use among adults with cystic fibrosis (CF) provides an opportunity for healthcare professionals to use the internet as a tool for patient education. The Toronto Adult Cystic Fibrosis website was developed, implemented, and evaluated (www.torontoadultcf.
View Article and Find Full Text PDFPatients with cystic fibrosis (CF) commonly suffer chronic respiratory infections, although systemic dissemination is relatively rare. Acute bacterial prostatitis presents dramatically and is believed to be mostly caused by local migration (with or without instrumentation) of the lower urinary tract and presents with a predictable microbial etiology. We report a case of a 26-year-old man presenting with acute Pseudomonas aeruginosa bacterial prostatitis due to hematogenous propagation from a chronic pulmonary infection.
View Article and Find Full Text PDFRectal 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.
Cochrane Database Syst Rev
November 2012
Background: 5-Aminosalicylic acid (5-ASA) is a first-line therapy for inducing and maintaining remission of mild and moderately active ulcerative colitis (UC). When the proximal margin of inflammation is distal to the splenic flexure, 5-ASA therapy can be delivered as a rectal suppository, foam or liquid enema.
Objectives: The primary objective was to assess the efficacy and safety of rectal 5-ASA for maintaining remission of distal UC.
Rectal 5-aminosalicylic acid for induction of remission in ulcerative colitis.
Cochrane Database Syst Rev
January 2010
Background: 5-Aminosalicylates (5-ASA) are considered a first-line therapy for inducing and maintaining remission of mild to moderately active ulcerative colitis (UC). When inflammation in UC is limited to the distal colon, 5-ASA can also be administered rectally as a suppository, enema or foam.
Objectives: A systematic review was undertaken to evaluate the efficacy of rectal 5-ASA for treating active distal UC.